Studying the Genetic Basis of Neurodevelopmental Channelopathies

The Scientist is bringing together a panel of experts to share their research, discuss current therapeutic approaches, and to offer their insights.

By The Scientist Creative Services Team | January 1, 2018


FREE Webinar

Wednesday, March 7, 2018
2:30-4:00 PM Eastern Time
Register Now

Neurodevelopmental channelopathies impact the responsiveness of cells in the central nervous system to typical electrochemical signals. These signal disruptions can range in severity, from mild to intense, leading to epilepsy and speech disturbances. In one example, genetic variations to a gene encoding a voltage-gated sodium channel (SCN3A) can result in neurodevelopmental delays and disturbances. Advanced Cell Diagnostics brings an expert whose research into the genetics of SCN3A-based channelopathies promises to untangle the web of SCN3A’s role in neurodevelopment and beyond. Attendees will have the opportunity to interact with experts, ask questions, and seek advice on topics related to their research.

Topics to be covered:

  • The molecular and mechanistic similarities and differences between neurodegenerative diseases
  • Whether primary and secondary neurodegeneration distinctions are based on biology

Register Now

Meet the Speakers:

Richard Smith, PhD
Postdoctoral Fellow, Christopher Walsh Laboratory
Harvard Medical School



Annelies Laeremans, PhD
Research Scientist R&D
Advanced Cell Diagnostics



Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. RNA Moves a Memory From One Snail to Another
  3. Could a Dose of Sunshine Make You Smarter?
  4. Sweden Cancels Agreement With Elsevier Over Open Access